Additionally, just my .02 but that drug sucks when

Additionally, just my .02 but that drug sucks when compared to K. First off, K has potential for use in 1/2 of all cancers while that drug was very specific for a small subset of lung cancer and only ~ 1/3 had a good response. Second, K is NON toxic while that drug caused pleural effusions which is really gonna hurt a patient already suffering from diminished lung function.

So the way I see it, we have the potential for much more dough.

***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.